Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!

By

Luke Timmerman

9

May

2018

Charting His Own Entrepreneurial Course: Ethan Perlstein on The Long Run

/

/

/

Today’s guest on The Long Run podcast is Ethan Perlstein. He’s outspoken on social media, unafraid to occasionally rattle cages with the industry powers that be. He’s followed an unusual entrepreneurial path, starting a Public Benefit company, raising money from non-traditional sources, embracing ‘radical transparency,’ building an unusual model-organism based platform for drug discovery, and using his Internet savvy to...

25

Apr

2018

What Can You Do With Genomics and AI? Alice Zhang on The Long Run

/

/

/

Today’s guest on The Long Run podcast is Alice Zhang. Let’s start with some basic background. Zhang studied systems biology at Princeton, graduated with honors, enrolled in an MD/PHD program at UCLA/Caltech, stayed there five years, quit, moved to Silicon Valley, and co-founded a company dedicated to using her knowledge for neurodegenerative drug discovery. She has been named among the...

11

Apr

2018

The Immune Sequencing Frontier: Harlan and Chad Robins on The Long Run

/

/

/

Today on The Long Run are a pair of guests — Harlan and Chad Robins. They are the brothers who co-founded Seattle-based Adaptive Biotechnologies almost a decade ago. Chad is the CEO, and Harlan is the head of innovation. Adaptive, for those unfamiliar, has a specialized focus on sequencing regions of B-cells and T-cells of the adaptive immune system where...

28

Mar

2018

Teaching and Mentoring the Next Generation: Vicki Sato on The Long Run Podcast

/

/

/

Today’s guest on The Long Run podcast is Vicki Sato. She’s one of the biotech industry’s pioneers. Sato started out as a classic academic scientist on the Harvard faculty. Beginning in the mid-1980s, and for about 20 years, the next phase of her career was as an executive at Biogen and Vertex Pharmaceuticals. Her fingerprints are all over a number...

26

Mar

2018

Mt. Everest: It’s Time

/

/

/

Six months of hard training is in the bank. Tomorrow morning, I will lug a pair of 120-liter gear bags to the airport and get on the plane for Kathmandu. Destination: Mt. Everest, 29,029 feet/8,848 meters. The summit of the highest mountain in the world. No matter what happens, three things are certain: I’ve given it everything I’ve got to prepare...

23

Mar

2018

The Data Wake-Up, AbbVie’s $5.8B Whiff, and a Regeneron-Alnylam Alliance

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

21

Mar

2018

TCR2 Therapeutics Grabs $125M to Take TCR Therapies, Sans HLA Screens, To the Clinic

/

/

/

All, Cancer, Venture Capital

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

16

Mar

2018

Shkreli Goes to Jail, Holmes Gets Fined, & Gilead CSO Exits With Barely a Peep

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

14

Mar

2018

From Rock DJ to Scientist to Entrepreneur: Michael Gilman on The Long Run Podcast

/

/

/

Today’s guest on The Long Run podcast is Michael Gilman. He’s the CEO of a pair of Boston-area biotech startups. One is Arrakis Therapeutics, a company attempting to make small molecule drugs against RNA targets. The other is Obsidian Therapeutics, a company seeking to take the next step in CAR-T immunotherapy, by carefully controlling dosing to avoid some of the...

12

Mar

2018

Photo Gallery: The Boston Cancer Summit

/

/

/

What a whirlwind last week was! The Seattle and Boston Cancer Summits were an East-West combo punch on behalf of the Everest Climb to Fight Cancer fundraising campaign for Fred Hutch. These events did the job: Bringing together leading thinkers and doers on both coasts, they both drew sellout, highly engaged crowds. The fundraising tally now stands at $326,000!! The...

12

Mar

2018

Photo Gallery: The Seattle Cancer Summit

/

/

/

What a whirlwind last week was! The Seattle and Boston Cancer Summits were an East-West combo punch on behalf of the Everest Climb to Fight Cancer fundraising campaign for Fred Hutch. These events did the job: Bringing together leading thinkers and doers on both coasts, they both drew sellout, highly engaged crowds. The fundraising tally now stands at $326,000!! The...

2

Mar

2018

Celgene Drops the Ball and a Flurry of VC Deals: Frontpoints

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

28

Feb

2018

Matching Up Technology & People: Bruce Booth on The Long Run Podcast

/

/

/

All, Venture Capital

Bruce Booth is the latest guest on The Long Run podcast. Booth, a partner with Atlas Venture, has made a name for himself the past few years as the author of the LifeSciVC blog. He writes about industry investment trends, the occasional news item from Atlas portfolio companies, and occasionally shines a light into the dark little corners of the...

26

Feb

2018

The Henri A. Termeer Tribute: An Uplifting Idea for a Tumultuous Time

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

23

Feb

2018

Gilead’s Latest CAR-T Domino, Takeda’s Deal Spree, & Merck’s Oncolytics Bet

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

16

Feb

2018

All-Star Lineup for Boston Cancer Summit, March 7: Novartis, J&J, Third Rock, Atlas

/

/

/

Timmerman Report is bringing together major East Coast cancer R&D players for an intimate half-day event on March 7: the Boston Cancer Summit. Join an all-star gathering of pharma executives, hot startups, and VCs making things happen in the treatment and diagnosis of cancer. Tickets are sold out. The conference will be at Sanofi Genzyme’s flagship building in the heart of Kendall Square....

15

Feb

2018

Mingle in Seattle with Genentech, Celgene, OrbiMed, 5AM & More, March 5

/

/

/

Exclusive Event, Powerhouse Lineup: Seattle Cancer Summit Seattle biotech events don’t get any better than this. Timmerman Report is bringing together major West Coast players for an intimate half-day event on March 5: the Seattle Cancer Summit. Tickets are limited and going fast. And all proceeds go to the Fred Hutchinson Cancer Research Center, as part of my Everest Climb to Fight...

14

Feb

2018

Building a Cancer R&D Engine To Last: David Schenkein on The Long Run

/

/

/

Today’s guest on The Long Run podcast is David Schenkein. He’s the CEO of Cambridge, Mass.-based Agios Pharmaceuticals. Agios was founded a decade ago on the then-provocative idea of fighting cancer via new understanding of metabolic pathways that get hijacked by cancer cells. The company has grown up quite a bit since. It went from concept to new chemical entities...

9

Feb

2018

BMS Makes Case for TMB, Express Scripts Sees Drug Price Slowdown, & Theravance Pockets $100M

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

5

Feb

2018

The Caveman’s Guide to Productivity

/

/

/

One TR subscriber already knew about some of my quirks: he and I rode in a van together for 26 hours straight to do the 200-mile Ragnar Reach the Beach Relay in New Hampshire. But when I published last month’s column detailing my Everest training, he wanted to know more. “I study performance pretty carefully, so all these kinds of questions fascinate...

1 2 3 … 19 Next ›